
IVI alternative for proliferative retinopathy?
US researchers have developed a proliferative retinopathy treatment that could offer a less-invasive alternative to intravitreal injections (IVI) for diabetic retinopathy, retinopathy of prematurity a

US researchers have developed a proliferative retinopathy treatment that could offer a less-invasive alternative to intravitreal injections (IVI) for diabetic retinopathy, retinopathy of prematurity a

A portable graphics processing unit (GPU) tested in Rwanda could help research centres in low- and middle-income countries contribute retinal scans to Global RETFound. The research consortium is

Tenpoint Therapeutics’ Yuvezzi, the first and only dual-agent eye drop, has received US Food and Drug Administration (FDA) approval for the treatment of presbyopia in adults. The approval of

Please take part in the NZ Optics 2026 Reader Survey to help us better understand how we can serve Aotearoa’s eyecare community.

Health New Zealand Te Whatu Ora has released a National Diabetes Roadmap to improve care, strengthen prevention and support better health outcomes for New Zealanders living with diabetes.

Alcon is expanding the Alcon Experience Academy, its on-demand learning platform offering tailored content for ophthalmologists, surgical support staff, optometrists and optometry retail support staff

Plans are underway for the third Women in Vision (WIV) Aotearoa Conference, set to take place on Auckland’s Waiheke Island from 4–6 November, immediately ahead of the Auckland RANZCO Congress. The the

Current darts world champion, Englishman Luke ‘The Nuke’ Littler, said he’s grateful his parents arranged surgery to correct his strabismus at an early age. Now 19 years old, Littler told Sky Sports h

Metformin use in people with diabetes was associated with significantly lower odds of developing intermediate age-related macular degeneration (AMD) over five years. Published in BMJ Open Ophthalmolog

US researchers have reported that hearing impairment may reduce the functional benefit patients gain from low-vision rehabilitation, even when their baseline visual ability is similar to that of patie

US researchers reported that switching patients with dry eye disease (DED) inadequately controlled on cyclosporine ophthalmic emulsion 0.05% to cyclosporine ophthalmic solution 0.09% improved both sig

Ophthalmology New Zealand (ONZ) is inviting business leaders, ophthalmologists, managers and technicians to its annual business forum on Saturday 9 May, hosted at the Crowne Plaza Queenstown. Themed ‘